Christine Klaskin
About Christine Klaskin
Christine M. Klaskin, 59, serves as Treasurer of MiNK Therapeutics and has held this role since July 2017; she is also Vice President, Finance at Agenus (since October 2006), having joined Agenus in 1996 as a finance manager after prior service as an audit manager at Arthur Andersen. She holds a Bachelor of Accountancy from The George Washington University . Ms. Klaskin’s compensation for services to MiNK is allocated from Agenus and she does not receive compensation directly from MiNK; she was not eligible for a MiNK annual bonus for fiscal 2024 and held no MiNK equity awards as of December 31, 2024 . As of April 24, 2025, she beneficially owned 5,789 MiNK shares, less than 1% of the class .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| MiNK Therapeutics, Inc. | Treasurer | Since Jul 2017 | — |
| Agenus Inc. | Finance Manager | 1996–2006 | — |
| Arthur Andersen | Audit Manager | Not disclosed | — |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| Agenus Inc. | Vice President, Finance | Since Oct 2006 | Compensation for services to MiNK is allocated from Agenus |
Fixed Compensation
| Metric | FY 2023 | FY 2024 |
|---|---|---|
| Salary allocated from Agenus for MiNK service ($) | $29,624 | $29,822 |
| Bonus ($) | — (not paid by MiNK) | — (not yet determined for others; not eligible for Klaskin) |
| Stock awards ($) | — | — |
| Option awards ($) | — | — |
| All other compensation ($) | — | — |
| Total ($) | $29,624 | $29,822 |
Performance Compensation
| Component | Metric | Target | Actual/Payout | Vesting |
|---|---|---|---|---|
| Annual bonus (MiNK) | Not eligible for FY 2024 | — | — | — |
| Equity awards (MiNK) | None in FY 2024 | — | — | — |
- For MiNK FY 2024 corporate context, the company set goals around clinical readouts, extending cash runway, scaling iNKT manufacturing, advancing combinations/engagers, and investor engagement; Ms. Klaskin was not eligible for a MiNK bonus for FY 2024 .
Equity Ownership & Alignment
| Metric | Apr 17, 2024 | Dec 16, 2024 | Apr 24, 2025 |
|---|---|---|---|
| Shares owned | 55,660 | 57,905 | 5,789 |
| Shares issuable (options/RSUs within 60 days) | — | — | — |
| Percent of class | <1% | <1% | <1% |
- Company equity awards outstanding: None held by Ms. Klaskin as of December 31, 2024 .
- Reverse stock split: MiNK effected a 1-for-10 reverse split on January 28, 2025, reflected in disclosures of option exercise prices and share counts elsewhere in the proxy .
- Pledging/hedging: MiNK maintains a Code of Ethics and a Securities Trading Policy (updated March 2023); no pledging or hedging by Ms. Klaskin is disclosed in the proxy .
Employment Terms
| Term | Detail |
|---|---|
| Employment agreement with MiNK | None; Ms. Klaskin is also a named executive officer of Agenus; a portion of her Agenus compensation is allocated to MiNK |
| Severance (MiNK) | None; MiNK does not provide severance or change-in-control benefits to Ms. Klaskin |
| Change-in-control (MiNK CIC Plan) | CIC Plan covers certain employees (VP+), e.g., CEO; Ms. Klaskin is not covered and has no CIC benefits at MiNK |
| Bonus eligibility (MiNK FY 2024) | Not eligible |
| Compensation determination | Determined by Agenus and its compensation committee for her role at Agenus; MiNK does not directly compensate her |
Investment Implications
- Compensation alignment: Klaskin’s pay is determined by Agenus and not directly by MiNK; she had no MiNK bonus eligibility and no MiNK equity awards in FY 2024, limiting direct pay-for-performance alignment and reducing vesting-driven selling pressure at MiNK .
- Ownership skin-in-the-game: Beneficial ownership is de minimis (<1% across periods), suggesting limited direct equity alignment relative to core MiNK executives .
- Retention and transition risk: Absence of MiNK severance/change-in-control economics reduces MiNK-specific retention hooks; continuity risk for the Treasurer function is more dependent on Agenus’s employment terms and priorities, given her dual role and compensation source .
- Governance/controls: MiNK’s Code of Ethics and Securities Trading Policy are in place; no red flags disclosed regarding pledging/hedging or related-party transactions tied to Klaskin in the proxy excerpts reviewed .